| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.876 | 0.005 | 0.876 | Analgesic | 0.871 0.005 CID_259381 | ||
| 0.742 | 0.003 | 0.742 | Anesthetic general | 0.254 0.048 CID_998 0.561 0.005 CID_259381 | ||
| 0.733 | 0.003 | 0.733 | Sigma receptor antagonist | 0.394 0.005 CID_259381 | ||
| 0.666 | 0.003 | 0.666 | Analgesic, opioid | 0.632 0.003 CID_259381 | ||
| 0.646 | 0.005 | 0.646 | Potassium channel (Voltage-sensitive) blocker | 0.368 0.032 CID_259381 | ||
| 0.627 | 0.007 | 0.627 | HERG channel blocker | 0.312 0.046 CID_259381 | ||
| 0.56 | 0.017 | 0.56 | Spasmolytic | 0.202 0.118 CID_998 0.353 0.052 CID_259381 | ||
| 0.541 | 0.004 | 0.541 | Anesthetic local | 0.125 0.063 CID_998 0.361 0.008 CID_259381 | ||
| 0.516 | 0.01 | 0.516 | Potassium channel blocker | 0.27 0.057 CID_259381 | ||
| 0.499 | 0.003 | 0.499 | Opioid mu receptor agonist | 0.443 0.003 CID_259381 | ||
| 0.492 | 0.004 | 0.492 | Opioid antagonist | 0.388 0.005 CID_259381 | ||
| 0.494 | 0.01 | 0.494 | Sigma receptor agonist | |||
| 0.475 | 0.004 | 0.475 | Opioid agonist | 0.437 0.004 CID_259381 | ||
| 0.466 | 0.004 | 0.466 | Opioid mu receptor antagonist | 0.377 0.004 CID_259381 | ||
| 0.439 | 0.038 | 0.619 | 5 Hydroxytryptamine release stimulant | 0.54 0.021 CID_998 0.619 0.013 CID_259381 | CID_259381 | |
| 0.35 | 0.005 | 0.35 | Opioid kappa receptor antagonist | 0.251 0.007 CID_259381 | ||
| 0.34 | 0.006 | 0.34 | Neurotrophic factor | 0.174 0.041 CID_998 0.222 0.019 CID_259381 | ||
| 0.347 | 0.021 | 0.347 | P-glycoprotein inhibitor | 0.149 0.118 CID_259381 | ||
| 0.331 | 0.011 | 0.331 | Neuropeptide Y2 antagonist | 0.195 0.128 CID_998 0.314 0.014 CID_259381 | ||
| 0.307 | 0.009 | 0.307 | Acetylcholine muscarinic antagonist | 0.217 0.02 CID_259381 | ||
| 0.288 | 0.004 | 0.288 | Acetylcholine M2 receptor antagonist | 0.188 0.007 CID_259381 | ||
| 0.287 | 0.004 | 0.314 | Opioid delta receptor agonist | 0.314 0.004 CID_259381 | CID_259381 | |
| 0.285 | 0.005 | 0.285 | Opioid delta receptor antagonist | 0.246 0.006 CID_259381 | ||
| 0.32 | 0.048 | 0.32 | Cardiotonic | |||
| 0.284 | 0.012 | 0.284 | Calcium channel blocker | 0.171 0.044 CID_259381 | ||
| 0.278 | 0.008 | 0.278 | Calcium channel (voltage-sensitive) blocker | 0.143 0.038 CID_259381 | ||
| 0.297 | 0.032 | 0.297 | 5 Hydroxytryptamine 1E antagonist | 0.25 0.074 CID_998 0.263 0.061 CID_259381 | ||
| 0.265 | 0.004 | 0.265 | Acetylcholine release stimulant | 0.132 0.032 CID_998 0.155 0.014 CID_259381 | ||
| 0.244 | 0.005 | 0.244 | Acetylcholine M3 receptor antagonist | 0.152 0.011 CID_259381 | ||
| 0.368 | 0.131 | 0.479 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.479 0.044 CID_998 0.414 0.088 CID_259381 | CID_998 | |
| 0.281 | 0.044 | 0.382 | Tyrosine 3 hydroxylase inhibitor | 0.382 0.01 CID_998 0.33 0.021 CID_259381 | CID_998 | |
| 0.255 | 0.02 | 0.255 | Cholinergic antagonist | 0.213 0.029 CID_259381 | ||
| 0.252 | 0.02 | 0.252 | Acetylcholine antagonist | 0.211 0.028 CID_259381 | ||
| 0.241 | 0.009 | 0.241 | Calcium channel N-type blocker | 0.189 0.019 CID_259381 | ||
| 0.232 | 0.009 | 0.232 | 5 Hydroxytryptamine 1 agonist | 0.07 0.028 CID_259381 | ||
| 0.231 | 0.009 | 0.231 | 5 Hydroxytryptamine 1F antagonist | 0.134 0.02 CID_259381 | ||
| 0.227 | 0.005 | 0.227 | Dopamine uptake inhibitor | 0.185 0.007 CID_259381 | ||
| 0.232 | 0.017 | 0.232 | Nav1.3 sodium channel blocker | 0.104 0.093 CID_998 0.167 0.038 CID_259381 | ||
| 0.274 | 0.068 | 0.274 | Ca(v)3.3 blocker | |||
| 0.242 | 0.043 | 0.244 | Neurotrophic factor enhancer | 0.244 0.042 CID_998 | CID_998 | |
| 0.208 | 0.01 | 0.24 | 5 Hydroxytryptamine uptake inhibitor | 0.24 0.009 CID_259381 | CID_259381 | |
| 0.202 | 0.014 | 0.202 | Neuropeptide Y antagonist | 0.175 0.017 CID_259381 | ||
| 0.2 | 0.018 | 0.2 | Alpha 2c adrenoreceptor antagonist | 0.126 0.045 CID_259381 | ||
| 0.193 | 0.019 | 0.193 | Alpha 2 adrenoreceptor antagonist | 0.162 0.024 CID_259381 | ||
| 0.173 | 0.003 | 0.173 | CC chemokine 5 receptor agonist | 0.094 0.029 CID_998 0.137 0.005 CID_259381 | ||
| 0.201 | 0.034 | 0.201 | Nav1.2 sodium channel blocker | 0.126 0.077 CID_998 0.127 0.075 CID_259381 | ||
| 0.248 | 0.082 | 0.248 | Gastrin inhibitor | 0.239 0.092 CID_998 0.247 0.083 CID_259381 | ||
| 0.179 | 0.015 | 0.179 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.185 | 0.027 | 0.185 | Neuropeptide Y1 antagonist | 0.126 0.108 CID_998 0.167 0.042 CID_259381 | ||
| 0.268 | 0.116 | 0.27 | Vasodilator, coronary | 0.27 0.115 CID_998 0.221 0.163 CID_259381 | CID_998 | |
| 0.164 | 0.014 | 0.164 | Dopamine D3 antagonist | 0.064 0.042 CID_259381 | ||
| 0.174 | 0.024 | 0.174 | Chemokine receptor antagonist | 0.15 0.032 CID_259381 | ||
| 0.153 | 0.004 | 0.153 | Sphingosine kinase inhibitor | 0.075 0.019 CID_998 0.108 0.006 CID_259381 | ||
| 0.159 | 0.01 | 0.159 | 5 Hydroxytryptamine 1A agonist | 0.054 0.027 CID_259381 | ||
| 0.159 | 0.012 | 0.159 | 5 Hydroxytryptamine 1B antagonist | 0.089 0.029 CID_259381 | ||
| 0.147 | 0.008 | 0.147 | Viral attachment inhibitor | 0.145 0.009 CID_259381 | ||
| 0.166 | 0.028 | 0.166 | Antihistaminic | |||
| 0.174 | 0.037 | 0.174 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.175 | 0.041 | 0.175 | 5 Hydroxytryptamine antagonist | 0.103 0.076 CID_259381 | ||
| 0.156 | 0.023 | 0.156 | Histamine H1 receptor antagonist | |||
| 0.233 | 0.1 | 0.43 | 5 Hydroxytryptamine uptake stimulant | 0.43 0.01 CID_998 0.382 0.018 CID_259381 | CID_998 | |
| 0.157 | 0.028 | 0.157 | Histamine antagonist | |||
| 0.152 | 0.025 | 0.152 | Dopamine antagonist | |||
| 0.127 | 0.004 | 0.127 | Sphingosine kinase 1 inhibitor | 0.082 0.005 CID_259381 | ||
| 0.153 | 0.032 | 0.153 | Nav1.1 sodium channel blocker | |||
| 0.126 | 0.005 | 0.126 | CC chemokine 5 receptor antagonist | 0.088 0.011 CID_259381 | ||
| 0.175 | 0.055 | 0.175 | Acetylcholine M1 receptor antagonist | 0.137 0.088 CID_259381 | ||
| 0.135 | 0.026 | 0.135 | 5 Hydroxytryptamine 1 antagonist | 0.063 0.06 CID_259381 | ||
| 0.114 | 0.005 | 0.114 | Potassium channel (Inward rectifier) blocker | |||
| 0.127 | 0.024 | 0.127 | CC chemokine receptor antagonist | 0.085 0.047 CID_259381 | ||
| 0.15 | 0.054 | 0.15 | Nav1.6 sodium channel blocker | 0.122 0.093 CID_259381 | ||
| 0.122 | 0.027 | 0.193 | 5 Hydroxytryptamine agonist | 0.193 0.015 CID_259381 | CID_259381 | |
| 0.224 | 0.132 | 0.224 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.136 | 0.046 | 0.136 | Alpha 2b adrenoreceptor antagonist | 0.094 0.081 CID_259381 | ||
| 0.279 | 0.189 | 0.448 | 5 Hydroxytryptamine release inhibitor | 0.448 0.052 CID_998 0.323 0.141 CID_259381 | CID_998 | |
| 0.098 | 0.008 | 0.098 | Sphingosine kinase 2 inhibitor | 0.063 0.028 CID_998 0.052 0.043 CID_259381 | ||
| 0.124 | 0.036 | 0.124 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.112 | 0.025 | 0.112 | Histamine H2 receptor antagonist | 0.078 0.069 CID_259381 | ||
| 0.147 | 0.065 | 0.221 | Toll-Like receptor 9 antagonist | 0.221 0.027 CID_259381 | CID_259381 | |
| 0.101 | 0.019 | 0.197 | Adrenaline uptake inhibitor | 0.197 0.006 CID_259381 | CID_259381 | |
| 0.12 | 0.038 | 0.178 | Prolactin inhibitor | 0.178 0.013 CID_998 0.144 0.025 CID_259381 | CID_998 | |
| 0.109 | 0.03 | 0.109 | Dopamine D2 antagonist | |||
| 0.106 | 0.03 | 0.106 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.099 | 0.023 | 0.099 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.18 | 0.106 | 0.258 | 5 Hydroxytryptamine 3E antagonist | 0.258 0.013 CID_998 0.187 0.088 CID_259381 | CID_998 | |
| 0.08 | 0.008 | 0.089 | Substance P antagonist | 0.089 0.006 CID_259381 | CID_259381 | |
| 0.137 | 0.065 | 0.206 | Toll-Like receptor antagonist | 0.206 0.028 CID_259381 | CID_259381 | |
| 0.129 | 0.058 | 0.142 | Sphingosine 1-phosphate receptor 4 antagonist | 0.142 0.041 CID_998 0.138 0.046 CID_259381 | CID_998 | |
| 0.118 | 0.048 | 0.118 | Alpha adrenoreceptor antagonist | |||
| 0.075 | 0.006 | 0.075 | Sigma 2 receptor antagonist | 0.033 0.015 CID_998 | ||
| 0.095 | 0.027 | 0.095 | Calcium channel L-type blocker | |||
| 0.194 | 0.127 | 0.277 | Interleukin agonist | 0.23 0.094 CID_998 0.277 0.061 CID_259381 | CID_259381 | |
| 0.168 | 0.101 | 0.195 | Psychostimulant | 0.195 0.083 CID_998 0.186 0.089 CID_259381 | CID_998 | |
| 0.102 | 0.036 | 0.102 | Adrenaline agonist | 0.087 0.049 CID_259381 | ||
| 0.085 | 0.021 | 0.085 | 5 Hydroxytryptamine 5A antagonist | 0.058 0.048 CID_259381 | ||
| 0.08 | 0.016 | 0.08 | Histamine H3 receptor antagonist | |||
| 0.08 | 0.017 | 0.08 | Neurokinin antagonist | 0.065 0.023 CID_259381 | ||
| 0.07 | 0.008 | 0.07 | Sigma 1 receptor antagonist | 0.024 0.02 CID_998 | ||
| 0.129 | 0.069 | 0.63 | Alpha-N-acetylglucosaminidase inhibitor | 0.63 0.004 CID_998 0.235 0.025 CID_259381 | CID_998 | |
| 0.138 | 0.082 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.168 0.015 CID_998 0.141 0.07 CID_259381 | CID_998 | |
| 0.106 | 0.05 | 0.122 | Nitric-oxide synthase inhibitor | 0.122 0.037 CID_259381 | CID_259381 | |
| 0.112 | 0.059 | 0.298 | Ferrochelatase inhibitor | 0.298 0.008 CID_998 0.188 0.025 CID_259381 | CID_998 | |
| 0.075 | 0.025 | 0.075 | Calcium channel T-type blocker | |||
| 0.147 | 0.098 | 0.147 | Antipruritic | |||
| 0.115 | 0.066 | 0.115 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.101 | 0.055 | 0.101 | Antiadrenergic | |||
| 0.062 | 0.017 | 0.062 | Opioid kappa receptor agonist | |||
| 0.07 | 0.026 | 0.07 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.098 | 0.055 | 0.098 | Adrenaline antagonist | |||
| 0.248 | 0.207 | 0.388 | Calcium channel L-type activator | 0.388 0.089 CID_998 0.328 0.134 CID_259381 | CID_998 | |
| 0.07 | 0.031 | 0.07 | Acetylcholine M5 receptor antagonist | |||
| 0.077 | 0.039 | 0.09 | Phospholipase D inhibitor | 0.079 0.035 CID_998 0.09 0.022 CID_259381 | CID_259381 | |
| 0.268 | 0.231 | 0.413 | Caspase 9 stimulant | 0.413 0.103 CID_998 | CID_998 | |
| 0.072 | 0.036 | 0.072 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.151 | 0.116 | 0.151 | DNA methylase inhibitor | 0.138 0.129 CID_259381 | ||
| 0.052 | 0.018 | 0.06 | Neurokinin 1 antagonist | 0.06 0.015 CID_259381 | CID_259381 | |
| 0.062 | 0.029 | 0.062 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.069 | 0.037 | 0.069 | Dopamine D4 antagonist | |||
| 0.114 | 0.083 | 0.241 | Cathepsin H inhibitor | 0.241 0.015 CID_998 0.118 0.077 CID_259381 | CID_998 | |
| 0.059 | 0.029 | 0.062 | Histamine agonist | 0.062 0.026 CID_259381 | CID_259381 | |
| 0.039 | 0.01 | 0.07 | Melatonin antagonist | 0.07 0.005 CID_259381 | CID_259381 | |
| 0.053 | 0.026 | 0.053 | Potassium channel Kv1.3 blocker | 0.045 0.035 CID_998 | ||
| 0.065 | 0.041 | 0.101 | 5 Hydroxytryptamine 2A agonist | 0.101 0.014 CID_259381 | CID_259381 | |
| 0.075 | 0.052 | 0.075 | Acetylcholine M4 receptor antagonist | 0.068 0.059 CID_259381 | ||
| 0.042 | 0.02 | 0.042 | Nociceptin (N/OFQ) receptor antagonist | 0.031 0.028 CID_259381 | ||
| 0.062 | 0.04 | 0.062 | Beta 2 adrenoreceptor agonist | |||
| 0.053 | 0.032 | 0.053 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.07 | 0.049 | 0.1 | CXC chemokine receptor antagonist | 0.1 0.025 CID_259381 | CID_259381 | |
| 0.058 | 0.038 | 0.058 | Potassium channel Kv1.5 blocker | |||
| 0.025 | 0.005 | 0.025 | CXC chemokine 5 receptor antagonist | |||
| 0.035 | 0.015 | 0.062 | Epoxide hydrolase 1 inhibitor | 0.062 0.004 CID_259381 | CID_259381 | |
| 0.025 | 0.005 | 0.031 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.031 0.004 CID_259381 | CID_259381 | |
| 0.091 | 0.071 | 0.109 | Sphingomyelinase inhibitor | 0.109 0.051 CID_998 | CID_998 | |
| 0.046 | 0.027 | 0.046 | Beta adrenoreceptor agonist | |||
| 0.076 | 0.058 | 0.094 | Interferon agonist | 0.094 0.034 CID_998 | CID_998 | |
| 0.093 | 0.076 | 0.106 | Glutamate (mGluR7) agonist | 0.106 0.049 CID_998 0.1 0.06 CID_259381 | CID_998 | |
| 0.063 | 0.046 | 0.063 | Interferon inducer | |||
| 0.141 | 0.125 | 0.163 | Neurotensin receptor agonist | 0.163 0.075 CID_998 0.163 0.074 CID_259381 | CID_259381 | |
| 0.056 | 0.039 | 0.059 | 5 Hydroxytryptamine 7 agonist | 0.059 0.032 CID_259381 | CID_259381 | |
| 0.074 | 0.057 | 0.106 | Nicotinic alpha4beta2 receptor antagonist | 0.106 0.026 CID_998 0.084 0.046 CID_259381 | CID_998 | |
| 0.033 | 0.017 | 0.033 | 5 Hydroxytryptamine 1D agonist | |||
| 0.03 | 0.014 | 0.03 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.024 | 0.009 | 0.042 | Melatonin 1 antagonist | 0.042 0.005 CID_259381 | CID_259381 | |
| 0.031 | 0.017 | 0.031 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.044 | 0.03 | 0.054 | Histamine H1 receptor agonist | 0.053 0.014 CID_998 0.054 0.014 CID_259381 | CID_259381 | |
| 0.048 | 0.036 | 0.048 | Bombesin 2 receptor antagonist | |||
| 0.125 | 0.113 | 0.125 | Growth hormone agonist | |||
| 0.088 | 0.076 | 0.088 | Alpha 2d adrenoreceptor antagonist | 0.086 0.083 CID_259381 | ||
| 0.055 | 0.044 | 0.07 | Cathepsin L inhibitor | 0.07 0.03 CID_998 0.057 0.041 CID_259381 | CID_998 | |
| 0.034 | 0.022 | 0.046 | Melatonin 1 agonist | 0.046 0.011 CID_259381 | CID_259381 | |
| 0.035 | 0.024 | 0.035 | Adenosine uptake inhibitor | |||
| 0.091 | 0.08 | 0.209 | Falcipain 3 inhibitor | 0.209 0.015 CID_998 | CID_998 | |
| 0.031 | 0.021 | 0.031 | CXC chemokine 3 receptor antagonist | |||
| 0.051 | 0.041 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | 0.056 0.032 CID_998 0.059 0.027 CID_259381 | CID_259381 | |
| 0.031 | 0.021 | 0.032 | Endothelial nitric-oxide synthase inhibitor | 0.032 0.02 CID_259381 | CID_259381 | |
| 0.037 | 0.027 | 0.037 | Delayed rectifier potassium channel blocker | |||
| 0.031 | 0.025 | 0.04 | Melatonin agonist | 0.04 0.015 CID_259381 | CID_259381 | |
| 0.077 | 0.071 | 0.082 | Ca(v)3.1 blocker | 0.082 0.054 CID_998 | CID_998 | |
| 0.052 | 0.047 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.037 | 0.032 | 0.074 | Dopamine D5 agonist | 0.074 0.007 CID_998 0.07 0.008 CID_259381 | CID_998 | |
| 0.043 | 0.039 | 0.073 | Dopamine transporter inhibitor | 0.073 0.019 CID_259381 | CID_259381 | |
| 0.098 | 0.094 | 0.098 | Cell adhesion inhibitor | |||
| 0.019 | 0.015 | 0.019 | Apolipoprotein B inhibitor | |||
| 0.065 | 0.061 | 0.067 | Epoxide hydrolase inhibitor | 0.067 0.058 CID_259381 | CID_259381 | |
| 0.037 | 0.033 | 0.037 | CC chemokine 3 receptor antagonist | |||
| 0.036 | 0.033 | 0.074 | GABA uptake inhibitor | 0.074 0.006 CID_998 | CID_998 | |
| 0.021 | 0.018 | 0.021 | Prostaglandin D2 antagonist | |||
| 0.064 | 0.062 | 0.127 | Aminopeptidase I inhibitor | 0.127 0.018 CID_998 | CID_998 | |
| 0.035 | 0.033 | 0.035 | Dopamine D3 agonist | |||
| 0.102 | 0.1 | 0.109 | Transcription factor STAT6 inhibitor | 0.109 0.082 CID_998 | CID_998 | |
| 0.049 | 0.048 | 0.049 | CC chemokine 2 receptor antagonist | |||
| 0.05 | 0.052 | 0.063 | Fibroblast growth factor 4 antagonist | 0.063 0.035 CID_259381 | CID_259381 | |
| 0.195 | 0.198 | 0.232 | Interleukin 2 agonist | 0.232 0.14 CID_259381 | CID_259381 | |
| 0.137 | 0.14 | 0.191 | Death-associated protein kinase 2 inhibitor | 0.191 0.042 CID_259381 | CID_259381 | |
| 0.081 | 0.087 | 0.095 | Glutamate release inhibitor | 0.095 0.051 CID_998 | CID_998 | |
| 0.07 | 0.076 | 0.089 | Ca(v)2.2 blocker | 0.089 0.057 CID_259381 | CID_259381 | |
| 0.117 | 0.125 | 0.222 | Thiol protease inhibitor | 0.222 0.033 CID_998 0.132 0.092 CID_259381 | CID_998 | |
| 0.111 | 0.121 | 0.137 | Sphingosine 1-phosphate receptor 2 antagonist | 0.137 0.061 CID_998 | CID_998 | |
| 0.049 | 0.059 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | 0.055 0.047 CID_998 | CID_998 | |
| 0.09 | 0.101 | 0.191 | Cholesterol synthesis inhibitor | 0.191 0.029 CID_998 | CID_998 | |
| 0.066 | 0.079 | 0.083 | Vanilloid 4 agonist | 0.082 0.036 CID_998 0.083 0.036 CID_259381 | CID_259381 | |
| 0.065 | 0.08 | 0.073 | Potassium channel (Tandem pore domain) blocker | 0.073 0.055 CID_998 | CID_998 | |
| 0.117 | 0.133 | 0.155 | Sphingosine 1-phosphate receptor 5 antagonist | 0.155 0.054 CID_998 | CID_998 | |
| 0.013 | 0.029 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.013 CID_259381 | CID_259381 | |
| 0.066 | 0.084 | 0.114 | Glycine receptor antagonist | 0.1 0.033 CID_998 0.114 0.022 CID_259381 | CID_259381 | |
| 0.021 | 0.039 | 0.031 | Acid ceramidase inhibitor | 0.031 0.009 CID_998 0.026 0.018 CID_259381 | CID_998 | |
| 0.056 | 0.075 | 0.059 | Prolactin release inhibitor | 0.059 0.055 CID_259381 | CID_259381 | |
| 0.027 | 0.047 | 0.047 | Cathepsin L1 inhibitor | 0.047 0.021 CID_998 | CID_998 | |
| 0.045 | 0.065 | 0.055 | Epithelial sodium channel blocker | 0.055 0.037 CID_998 0.055 0.037 CID_259381 | CID_259381 | |
| 0.021 | 0.041 | 0.036 | Trypsin II inhibitor | 0.036 0.015 CID_998 | CID_998 | |
| 0.081 | 0.103 | 0.136 | 5 Hydroxytryptamine 3A agonist | 0.136 0.044 CID_998 0.131 0.047 CID_259381 | CID_998 | |
| 0.065 | 0.088 | 0.112 | Histamine N-methyltransferase inhibitor | 0.112 0.035 CID_998 | CID_998 | |
| 0.07 | 0.094 | 0.219 | Aminopeptidase B inhibitor | 0.219 0.017 CID_998 | CID_998 | |
| 0.015 | 0.04 | 0.026 | Motilin receptor agonist | 0.026 0.012 CID_259381 | CID_259381 | |
| 0.102 | 0.126 | 0.125 | Cytidine deaminase inhibitor | 0.125 0.096 CID_259381 | CID_259381 | |
| 0.015 | 0.04 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 CID_998 | CID_998 | |
| 0.18 | 0.205 | 0.305 | Antithrombotic | 0.305 0.085 CID_998 | CID_998 | |
| 0.05 | 0.075 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.053 CID_998 | CID_998 | |
| 0.032 | 0.058 | 0.039 | Plasmepsin II inhibitor | 0.039 0.033 CID_259381 | CID_259381 | |
| 0.118 | 0.145 | 0.14 | Amyloid beta precursor protein antagonist | 0.14 0.113 CID_998 | CID_998 | |
| 0.075 | 0.104 | 0.32 | GABA C receptor agonist | 0.32 0.008 CID_998 0.286 0.01 CID_259381 | CID_998 | |
| 0.058 | 0.087 | 0.118 | GABA aminotransferase inhibitor | 0.118 0.017 CID_998 | CID_998 | |
| 0.072 | 0.102 | 0.146 | Creatine kinase inhibitor | 0.146 0.025 CID_998 | CID_998 | |
| 0.037 | 0.067 | 0.051 | Heme oxygenase inhibitor | 0.051 0.012 CID_998 | CID_998 | |
| 0.014 | 0.045 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.019 CID_259381 | CID_259381 | |
| 0.108 | 0.14 | 0.194 | Hexokinase inhibitor | 0.194 0.039 CID_998 | CID_998 | |
| 0.052 | 0.085 | 0.061 | Beta 3 adrenoreceptor antagonist | 0.061 0.054 CID_259381 | CID_259381 | |
| 0.012 | 0.046 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.013 CID_998 0.022 0.013 CID_259381 | CID_259381 | |
| 0.047 | 0.081 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | 0.065 0.033 CID_998 | CID_998 | |
| 0.057 | 0.093 | 0.088 | Glycine receptor agonist | 0.088 0.03 CID_998 0.088 0.03 CID_259381 | CID_259381 | |
| 0.024 | 0.062 | 0.043 | Oxytocin agonist | 0.043 0.029 CID_998 | CID_998 | |
| 0.055 | 0.094 | 0.09 | Calcium antagonist | 0.09 0.055 CID_998 | CID_998 | |
| 0.062 | 0.103 | 0.117 | Inducible nitric-oxide synthase inhibitor | 0.117 0.026 CID_259381 | CID_259381 | |
| 0.064 | 0.109 | 0.103 | Caspase 7 inhibitor | 0.103 0.025 CID_998 | CID_998 | |
| 0.018 | 0.064 | 0.025 | Myristoyl transferase inhibitor | 0.025 0.023 CID_259381 | CID_259381 | |
| 0.025 | 0.071 | 0.066 | Adenosine deaminase inhibitor | 0.066 0.016 CID_998 | CID_998 | |
| 0.033 | 0.079 | 0.059 | Acetylcholine muscarinic agonist | 0.059 0.035 CID_259381 | CID_259381 | |
| 0.047 | 0.093 | 0.123 | Protease 3C (Human rhinovirus) inhibitor | 0.123 0.009 CID_998 0.059 0.054 CID_259381 | CID_998 | |
| 0.072 | 0.119 | 0.202 | GABA C receptor rho-1 antagonist | 0.151 0.021 CID_998 0.202 0.008 CID_259381 | CID_259381 | |
| 0.038 | 0.087 | 0.115 | Cyclin A2 inhibitor | 0.115 0.02 CID_259381 | CID_259381 | |
| 0.086 | 0.134 | 0.151 | Toll-Like receptor 2 antagonist | 0.151 0.052 CID_998 0.149 0.053 CID_259381 | CID_998 | |
| 0.076 | 0.125 | 0.193 | Proteasome inhibitor | 0.193 0.027 CID_998 | CID_998 | |
| 0.023 | 0.073 | 0.049 | Acetylcholine M1 receptor agonist | 0.049 0.026 CID_259381 | CID_259381 | |
| 0.038 | 0.089 | 0.056 | Fatty acid synthase inhibitor | 0.056 0.041 CID_259381 | CID_259381 | |
| 0.045 | 0.096 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.069 0.012 CID_998 | CID_998 | |
| 0.07 | 0.121 | 0.144 | Interleukin 1 beta converting enzyme inhibitor | 0.144 0.02 CID_998 | CID_998 | |
| 0.099 | 0.151 | 0.135 | Vanilloid 1 agonist | 0.135 0.058 CID_998 | CID_998 | |
| 0.144 | 0.197 | 0.526 | Superoxide dismutase inhibitor | 0.526 0.011 CID_998 0.214 0.103 CID_259381 | CID_998 | |
| 0.038 | 0.092 | 0.063 | Acetylcholine M5 receptor agonist | 0.063 0.052 CID_998 | CID_998 | |
| 0.03 | 0.084 | 0.051 | Kainate receptor agonist | 0.051 0.013 CID_998 | CID_998 | |
| 0.023 | 0.078 | 0.058 | Somatostatin 4 agonist | 0.058 0.013 CID_259381 | CID_259381 | |
| 0.027 | 0.082 | 0.044 | Nicotinic receptor alpha3 subunit antagonist | 0.044 0.03 CID_998 | CID_998 | |
| 0.033 | 0.09 | 0.084 | Prolyl endopeptidase inhibitor | 0.084 0.009 CID_998 | CID_998 | |
| 0.034 | 0.091 | 0.105 | Cyclin A inhibitor | 0.105 0.021 CID_259381 | CID_259381 | |
| 0.179 | 0.238 | 0.48 | GABA C receptor rho-3 antagonist | 0.48 0.032 CID_998 0.336 0.094 CID_259381 | CID_998 | |
| 0.067 | 0.129 | 0.114 | Estrogen-related receptor beta agonist | 0.114 0.013 CID_998 | CID_998 | |
| 0.119 | 0.182 | 0.34 | Succinate dehydrogenase inhibitor | 0.34 0.006 CID_998 0.157 0.1 CID_259381 | CID_998 | |
| 0.033 | 0.096 | 0.064 | Dopamine beta hydroxylase inhibitor | 0.064 0.012 CID_998 | CID_998 | |
| 0.033 | 0.097 | 0.09 | Alpha-mannosidase inhibitor | 0.09 0.008 CID_998 0.052 0.04 CID_259381 | CID_998 | |
| 0.024 | 0.088 | 0.058 | Histamine H2 receptor agonist | 0.058 0.016 CID_998 | CID_998 | |
| 0.048 | 0.114 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.055 CID_998 0.058 0.057 CID_259381 | CID_259381 | |
| 0.032 | 0.098 | 0.051 | Histamine H4 receptor antagonist | 0.051 0.029 CID_259381 | CID_259381 | |
| 0.014 | 0.082 | 0.027 | Lysophosphatidic acid receptor 1 agonist | 0.027 0.014 CID_998 | CID_998 | |
| 0.05 | 0.119 | 0.102 | Exportin-1 inhibitor | 0.102 0.008 CID_998 | CID_998 | |
| 0.071 | 0.14 | 0.221 | GABA C receptor antagonist | 0.159 0.025 CID_998 0.221 0.009 CID_259381 | CID_259381 | |
| 0.014 | 0.084 | 0.033 | Vanilloid 2 agonist | 0.033 0.007 CID_998 | CID_998 | |
| 0.01 | 0.081 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.015 CID_998 | CID_998 | |
| 0.103 | 0.175 | 0.148 | DNA methyltransferase I inhibitor | 0.148 0.106 CID_259381 | CID_259381 | |
| 0.052 | 0.125 | 0.095 | Acetylcholine agonist | 0.095 0.051 CID_259381 | CID_259381 | |
| 0.043 | 0.116 | 0.056 | Leukotriene C antagonist | 0.056 0.041 CID_998 | CID_998 | |
| 0.013 | 0.087 | 0.032 | Cathepsin K inhibitor | 0.032 0.013 CID_998 | CID_998 | |
| 0.048 | 0.123 | 0.087 | Acetylcholine nicotinic agonist | 0.087 0.048 CID_259381 | CID_259381 | |
| 0.037 | 0.112 | 0.194 | Catalase inhibitor | 0.194 0.016 CID_998 | CID_998 | |
| 0.06 | 0.137 | 0.201 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.201 0.015 CID_998 | CID_998 | |
| 0.026 | 0.107 | 0.087 | Acyl-CoA dehydrogenase inhibitor | 0.087 0.02 CID_998 | CID_998 | |
| 0.121 | 0.202 | 0.15 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.15 0.134 CID_259381 | CID_259381 | |
| 0.006 | 0.088 | 0.017 | Nicotinic alpha4 receptor agonist | 0.017 0.011 CID_259381 | CID_259381 | |
| 0.007 | 0.09 | 0.014 | Cyclin D2 inhibitor | 0.014 0.008 CID_259381 | CID_259381 | |
| 0.045 | 0.129 | 0.076 | Trypsin inhibitor | 0.076 0.029 CID_998 | CID_998 | |
| 0.021 | 0.107 | 0.082 | Mannosidase inhibitor | 0.082 0.008 CID_998 0.044 0.034 CID_259381 | CID_998 | |
| 0.023 | 0.11 | 0.036 | Potassium channel Kv1.1 blocker | 0.036 0.03 CID_998 | CID_998 | |
| 0.052 | 0.139 | 0.063 | MDM2 inhibitor | 0.063 0.062 CID_998 | CID_998 | |
| 0.02 | 0.109 | 0.07 | Geranyltranstransferase inhibitor | 0.07 0.008 CID_998 | CID_998 | |
| 0.039 | 0.129 | 0.142 | Cathepsin G inhibitor | 0.142 0.022 CID_998 | CID_998 | |
| 0.011 | 0.101 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 CID_998 | CID_998 | |
| 0.028 | 0.118 | 0.123 | Biliverdin reductase inhibitor | 0.123 0.013 CID_998 | CID_998 | |
| 0.025 | 0.117 | 0.06 | Lysophosphatidic acid 3 receptor antagonist | 0.06 0.023 CID_998 | CID_998 | |
| 0.004 | 0.097 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 CID_998 | CID_998 | |
| 0.113 | 0.207 | 0.173 | Phospholipase C inhibitor | 0.173 0.069 CID_998 0.171 0.071 CID_259381 | CID_998 | |
| 0.016 | 0.112 | 0.027 | Estrogen-related receptor gamma antagonist | 0.027 0.022 CID_998 | CID_998 | |
| 0.048 | 0.146 | 0.069 | Calcium channel P-type blocker | 0.069 0.03 CID_998 | CID_998 | |
| 0.031 | 0.129 | 0.069 | Cyclin D1 inhibitor | 0.069 0.029 CID_998 | CID_998 | |
| 0.126 | 0.225 | 0.181 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.181 0.091 CID_998 | CID_998 | |
| 0.024 | 0.124 | 0.05 | Nicotinic neuronal receptor agonist | 0.05 0.045 CID_259381 | CID_259381 | |
| 0.011 | 0.111 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.006 CID_998 | CID_998 | |
| 0.039 | 0.141 | 0.092 | Thrombin inhibitor | 0.092 0.031 CID_998 | CID_998 | |
| 0.043 | 0.145 | 0.069 | Somatostatin 1 agonist | 0.069 0.066 CID_259381 | CID_259381 | |
| 0.057 | 0.159 | 0.087 | MAP kinase kinase 7 inhibitor | 0.077 0.055 CID_998 0.087 0.03 CID_259381 | CID_259381 | |
| 0.032 | 0.135 | 0.21 | Cathepsin B inhibitor | 0.21 0.005 CID_998 | CID_998 | |
| 0.029 | 0.132 | 0.063 | Alpha 2 adrenoreceptor agonist | 0.063 0.039 CID_259381 | CID_259381 | |
| 0.019 | 0.122 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.022 CID_998 | CID_998 | |
| 0.022 | 0.125 | 0.041 | Histone deacetylase 9 inhibitor | 0.041 0.024 CID_998 | CID_998 | |
| 0.009 | 0.112 | 0.035 | Nicotinic alpha4beta2 receptor agonist | 0.035 0.011 CID_259381 | CID_259381 | |
| 0.143 | 0.247 | 0.195 | Immunomodulator | 0.195 0.17 CID_259381 | CID_259381 | |
| 0.014 | 0.117 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 CID_998 | CID_998 | |
| 0.069 | 0.173 | 0.179 | DOPA decarboxylase inhibitor | 0.179 0.01 CID_998 | CID_998 | |
| 0.026 | 0.132 | 0.093 | Carbamoyl phosphate synthetase inhibitor | 0.093 0.023 CID_998 | CID_998 | |
| 0.012 | 0.12 | 0.052 | Fumarate hydratase inhibitor | 0.052 0.013 CID_998 | CID_998 | |
| 0.094 | 0.202 | 0.168 | Adenylate cyclase stimulant | 0.168 0.038 CID_998 0.14 0.081 CID_259381 | CID_998 | |
| 0.038 | 0.148 | 0.07 | Acetylcholine nicotinic antagonist | 0.07 0.069 CID_998 | CID_998 | |
| 0.021 | 0.131 | 0.045 | Nerve growth factor antagonist | 0.045 0.026 CID_998 | CID_998 | |
| 0.079 | 0.189 | 0.173 | Anticoagulant | 0.173 0.065 CID_998 | CID_998 | |
| 0.099 | 0.21 | 0.138 | Pregnane X receptor agonist | 0.138 0.079 CID_998 0.124 0.118 CID_259381 | CID_998 | |
| 0.01 | 0.122 | 0.019 | Caspase 8 inhibitor | 0.019 0.016 CID_998 | CID_998 | |
| 0.068 | 0.181 | 0.15 | Cyclooxygenase 3 inhibitor | 0.15 0.048 CID_998 | CID_998 | |
| 0.028 | 0.143 | 0.054 | Carbonic anhydrase stimulant | 0.054 0.048 CID_998 | CID_998 | |
| 0.017 | 0.133 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.023 CID_998 | CID_998 | |
| 0.029 | 0.145 | 0.047 | Squalene epoxidase inhibitor | 0.047 0.039 CID_998 | CID_998 | |
| 0.145 | 0.263 | 0.299 | Insulysin inhibitor | 0.299 0.059 CID_998 0.202 0.154 CID_259381 | CID_998 | |
| 0.053 | 0.17 | 0.332 | Triose-phosphate isomerase inhibitor | 0.332 0.004 CID_998 | CID_998 | |
| 0.052 | 0.17 | 0.371 | UDP-glucose 4-epimerase inhibitor | 0.371 0.007 CID_998 | CID_998 | |
| 0.016 | 0.134 | 0.062 | Oleamide hydrolase inhibitor | 0.062 0.019 CID_998 | CID_998 | |
| 0.06 | 0.178 | 0.114 | Mucolytic | 0.114 0.061 CID_998 | CID_998 | |
| 0.022 | 0.14 | 0.453 | Alcohol oxidase inhibitor | 0.453 0.004 CID_998 | CID_998 | |
| 0.018 | 0.136 | 0.037 | Membrane dipeptidase inhibitor | 0.037 0.032 CID_998 | CID_998 | |
| 0.017 | 0.136 | 0.027 | Hedgehog signaling activator | 0.027 0.02 CID_998 | CID_998 | |
| 0.032 | 0.154 | 0.064 | Glucosylceramidase inhibitor | 0.064 0.027 CID_998 0.054 0.039 CID_259381 | CID_998 | |
| 0.132 | 0.254 | 0.315 | Cholesterol antagonist | 0.315 0.082 CID_998 | CID_998 | |
| 0.027 | 0.149 | 0.047 | Cytokine production stimulant | 0.047 0.039 CID_998 | CID_998 | |
| 0.132 | 0.255 | 0.177 | Peptidyltransferase inhibitor | 0.177 0.134 CID_259381 | CID_259381 | |
| 0.046 | 0.17 | 0.135 | Chymotrypsin inhibitor | 0.135 0.021 CID_998 | CID_998 | |
| 0.004 | 0.128 | 0.034 | 3C-Like protease (MERS coronavirus) inhibitor | 0.034 0.002 CID_998 | CID_998 | |
| 0.005 | 0.13 | 0.018 | Nicotinic acid receptor 1 antagonist | 0.018 0.011 CID_998 | CID_998 | |
| 0.032 | 0.159 | 0.228 | Glutamate decarboxylase inhibitor | 0.228 0.005 CID_998 | CID_998 | |
| 0.03 | 0.157 | 0.215 | Porphobilinogen synthase inhibitor | 0.215 0.01 CID_998 | CID_998 | |
| 0.039 | 0.166 | 0.057 | Ryanodine receptor antagonist | 0.057 0.047 CID_998 | CID_998 | |
| 0.021 | 0.149 | 0.2 | Argininosuccinate synthase inhibitor | 0.2 0.008 CID_998 | CID_998 | |
| 0.002 | 0.131 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 CID_998 | CID_998 | |
| 0.026 | 0.158 | 0.059 | Neuronal nicotinic receptor antagonist | 0.059 0.055 CID_998 | CID_998 | |
| 0.039 | 0.172 | 0.119 | Glutamate dehydrogenase inhibitor | 0.119 0.023 CID_998 | CID_998 | |
| 0.013 | 0.147 | 0.047 | Ribonucleoside-diphosphate reductase inhibitor | 0.047 0.043 CID_998 | CID_998 | |
| 0.034 | 0.17 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.05 CID_259381 | CID_259381 | |
| 0.049 | 0.185 | 0.087 | GABA B receptor agonist | 0.087 0.03 CID_998 | CID_998 | |
| 0.005 | 0.141 | 0.017 | Thromboxane A2 agonist | 0.017 0.009 CID_998 | CID_998 | |
| 0.012 | 0.149 | 0.046 | Ribonucleotide reductase inhibitor | 0.046 0.045 CID_998 | CID_998 | |
| 0.023 | 0.16 | 0.067 | Cyclin-dependent kinase 6 inhibitor | 0.067 0.034 CID_259381 | CID_259381 | |
| 0.053 | 0.194 | 0.117 | Lanosterol 14 alpha demethylase inhibitor | 0.117 0.034 CID_998 | CID_998 | |
| 0.003 | 0.15 | 0.015 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 CID_998 | CID_998 | |
| 0.003 | 0.15 | 0.015 | Carbonic anhydrase X inhibitor | 0.015 0.014 CID_998 | CID_998 | |
| 0.021 | 0.168 | 0.049 | Beta 1 adrenoreceptor antagonist | 0.049 0.048 CID_998 | CID_998 | |
| 0.057 | 0.206 | 0.121 | Carbonic anhydrase XV inhibitor | 0.121 0.046 CID_998 | CID_998 | |
| 0.064 | 0.213 | 0.22 | TRPA1 agonist | 0.22 0.008 CID_998 | CID_998 | |
| 0.112 | 0.262 | 0.142 | Heat shock protein 70 antagonist | 0.142 0.068 CID_998 | CID_998 | |
| 0.055 | 0.206 | 0.146 | Caspase 3 inhibitor | 0.146 0.031 CID_998 | CID_998 | |
| 0.015 | 0.167 | 0.141 | Aminopeptidase N inhibitor | 0.141 0.006 CID_998 | CID_998 | |
| 0.041 | 0.194 | 0.084 | Glutamate (mGluR6) antagonist | 0.084 0.02 CID_998 | CID_998 | |
| 0.098 | 0.252 | 0.191 | ATPase inhibitor | 0.191 0.045 CID_998 | CID_998 | |
| 0.013 | 0.166 | 0.1 | Ornithine carbamoyltransferase inhibitor | 0.1 0.016 CID_998 | CID_998 | |
| 0.013 | 0.167 | 0.04 | Histone deacetylase 7 inhibitor | 0.04 0.023 CID_998 | CID_998 | |
| 0.034 | 0.188 | 0.101 | Glutamate (mGluR7) antagonist | 0.101 0.01 CID_998 | CID_998 | |
| 0.086 | 0.24 | 0.473 | Aldehyde oxidase inhibitor | 0.473 0.037 CID_998 | CID_998 | |
| 0.022 | 0.177 | 0.161 | Aminopeptidase microsomal inhibitor | 0.161 0.006 CID_998 | CID_998 | |
| 0.03 | 0.187 | 0.117 | Purinergic P2X1 antagonist | 0.117 0.012 CID_998 | CID_998 | |
| 0.061 | 0.218 | 0.258 | Adenylate kinase inhibitor | 0.258 0.009 CID_998 | CID_998 | |
| 0.015 | 0.173 | 0.026 | Glucosylceramidase stimulant | 0.026 0.023 CID_998 | CID_998 | |
| 0.047 | 0.209 | 0.13 | Anabolic | 0.13 0.031 CID_998 | CID_998 | |
| 0.064 | 0.227 | 0.116 | CDK3/cyclin E inhibitor | 0.116 0.061 CID_259381 | CID_259381 | |
| 0.014 | 0.177 | 0.04 | Glutamate (mGluR3) antagonist | 0.04 0.021 CID_998 | CID_998 | |
| 0.083 | 0.248 | 0.217 | Melanin inhibitor | 0.217 0.035 CID_998 | CID_998 | |
| 0.019 | 0.185 | 0.061 | Cyclin A1 inhibitor | 0.061 0.036 CID_259381 | CID_259381 | |
| 0.019 | 0.186 | 0.051 | Glutamate (mGluR8) agonist | 0.051 0.011 CID_998 | CID_998 | |
| 0.008 | 0.176 | 0.022 | Prostaglandin F2 alpha agonist | 0.022 0.016 CID_998 | CID_998 | |
| 0.022 | 0.192 | 0.104 | Glucose-6-phosphate isomerase inhibitor | 0.104 0.004 CID_998 | CID_998 | |
| 0.023 | 0.193 | 0.089 | Amidase inhibitor | 0.089 0.031 CID_998 | CID_998 | |
| 0.028 | 0.2 | 0.056 | 5 Hydroxytryptamine 3 agonist | 0.056 0.055 CID_998 | CID_998 | |
| 0.008 | 0.181 | 0.021 | Retinoid X beta receptor antagonist | 0.021 0.014 CID_998 | CID_998 | |
| 0.011 | 0.184 | 0.059 | Carbonic anhydrase VB inhibitor | 0.059 0.036 CID_998 | CID_998 | |
| 0.039 | 0.213 | 0.088 | Expectorant | 0.088 0.083 CID_998 | CID_998 | |
| 0.09 | 0.265 | 0.129 | Death-associated protein kinase 1 inhibitor | 0.129 0.084 CID_259381 | CID_259381 | |
| 0.011 | 0.186 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.018 CID_998 | CID_998 | |
| 0.069 | 0.246 | 0.2 | Arachidonic acid antagonist | 0.2 0.033 CID_998 | CID_998 | |
| 0.023 | 0.2 | 0.066 | Carbonic anhydrase VA inhibitor | 0.066 0.051 CID_998 | CID_998 | |
| 0.118 | 0.297 | 0.221 | RNA-directed DNA polymerase inhibitor | 0.221 0.073 CID_998 0.182 0.129 CID_259381 | CID_998 | |
| 0.03 | 0.209 | 0.072 | Pregnane X receptor antagonist | 0.072 0.012 CID_998 | CID_998 | |
| 0.007 | 0.187 | 0.022 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 CID_998 | CID_998 | |
| 0.156 | 0.336 | 0.238 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.238 0.082 CID_259381 | CID_259381 | |
| 0.066 | 0.247 | 0.307 | Factor V inhibitor | 0.307 0.002 CID_998 | CID_998 | |
| 0.006 | 0.187 | 0.033 | Nicotinic alpha3beta4 receptor agonist | 0.033 0.016 CID_259381 | CID_259381 | |
| 0.121 | 0.302 | 0.159 | MAP kinase kinase 5 inhibitor | 0.159 0.118 CID_259381 | CID_259381 | |
| 0.119 | 0.302 | 0.194 | Vasodilator, peripheral | 0.194 0.184 CID_998 0.194 0.183 CID_259381 | CID_259381 | |
| 0.033 | 0.217 | 0.051 | Kallikrein 1 inhibitor | 0.051 0.05 CID_998 | CID_998 | |
| 0.022 | 0.207 | 0.142 | Phenylalanine 4-hydroxylase inhibitor | 0.142 0.013 CID_998 | CID_998 | |
| 0.005 | 0.19 | 0.208 | Calpain 1 inhibitor | 0.208 0.002 CID_998 | CID_998 | |
| 0.077 | 0.263 | 0.204 | GABA C receptor rho-2 antagonist | 0.204 0.027 CID_998 0.154 0.068 CID_259381 | CID_998 | |
| 0.018 | 0.205 | 0.217 | Phosphofructokinase-1 inhibitor | 0.217 0.01 CID_998 | CID_998 | |
| 0.084 | 0.272 | 0.283 | 3C-like protease (Human coronavirus) inhibitor | 0.283 0.015 CID_998 | CID_998 | |
| 0.001 | 0.19 | 0.088 | Antibiotic Macrolide-like | 0.088 0.003 CID_998 | CID_998 | |
| 0.007 | 0.196 | 0.036 | Free fatty acid receptor 1 antagonist | 0.036 0.021 CID_998 | CID_998 | |
| 0.035 | 0.225 | 0.132 | Protease inhibitor | 0.132 0.039 CID_998 | CID_998 | |
| 0.088 | 0.284 | 0.3 | Calpain inhibitor | 0.3 0.03 CID_998 | CID_998 | |
| 0.017 | 0.214 | 0.117 | Plasmin inhibitor | 0.117 0.015 CID_998 | CID_998 | |
| 0.048 | 0.247 | 0.123 | Granulocyte macrophage colony stimulating factor agonist | 0.123 0.014 CID_998 | CID_998 | |
| 0.136 | 0.336 | 0.339 | Calcium channel activator | 0.339 0.058 CID_998 | CID_998 | |
| 0.017 | 0.216 | 0.048 | Phenylethanolamine N methyltransferase inhibitor | 0.048 0.017 CID_259381 | CID_259381 | |
| 0.103 | 0.303 | 0.428 | Calpain 2 inhibitor | 0.428 0.047 CID_998 | CID_998 | |
| 0.007 | 0.208 | 0.033 | Nicotinic acid receptor 2 antagonist | 0.033 0.009 CID_998 | CID_998 | |
| 0.021 | 0.223 | 0.05 | Lysine-specific demethylase 1A inhibitor | 0.05 0.046 CID_259381 | CID_259381 | |
| 0.018 | 0.22 | 0.059 | Carbonic anhydrase V inhibitor | 0.059 0.055 CID_998 | CID_998 | |
| 0.019 | 0.222 | 0.105 | Aconitate hydratase inhibitor | 0.105 0.008 CID_998 | CID_998 | |
| 0.02 | 0.223 | 0.047 | HCV NS3/NS4A protease inhibitor | 0.047 0.039 CID_998 | CID_998 | |
| 0.044 | 0.252 | 0.126 | NADH dehydrogenase inhibitor | 0.126 0.025 CID_998 | CID_998 | |
| 0.128 | 0.338 | 0.321 | Histamine release inhibitor | 0.321 0.113 CID_998 | CID_998 | |
| 0.057 | 0.27 | 0.297 | Peroxidase inhibitor | 0.297 0.038 CID_998 | CID_998 | |
| 0.005 | 0.225 | 0.034 | Glutamate (mGluR1a) agonist | 0.034 0.007 CID_998 | CID_998 | |
| 0.003 | 0.225 | 0.037 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.037 0.014 CID_998 | CID_998 | |
| 0.02 | 0.242 | 0.137 | Histidine decarboxylase inhibitor | 0.137 0.022 CID_998 | CID_998 | |
| 0.025 | 0.248 | 0.068 | Dihydroorotate oxidase inhibitor | 0.068 0.019 CID_998 | CID_998 | |
| 0.021 | 0.245 | 0.041 | Glutamate (mGluR group III) antagonist | 0.041 0.038 CID_998 | CID_998 | |
| 0.014 | 0.238 | 0.032 | Glutamate (mGluR3) agonist | 0.032 0.024 CID_998 | CID_998 | |
| 0.016 | 0.242 | 0.07 | AICAR transformylase inhibitor | 0.07 0.01 CID_998 | CID_998 | |
| 0.067 | 0.296 | 0.253 | Immunostimulant | 0.253 0.095 CID_998 | CID_998 | |
| 0.02 | 0.25 | 0.042 | Glutamate (mGluR4) antagonist | 0.042 0.034 CID_998 | CID_998 | |
| 0.018 | 0.251 | 0.081 | Sphingosine 1-phosphate receptor 4 agonist | 0.081 0.036 CID_998 | CID_998 | |
| 0.009 | 0.244 | 0.049 | Glutamate (mGluR group I) agonist | 0.049 0.032 CID_998 | CID_998 | |
| 0.019 | 0.256 | 0.036 | Vanilloid 3 antagonist | 0.036 0.035 CID_998 | CID_998 | |
| 0.014 | 0.253 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.014 CID_998 | CID_998 | |
| 0.006 | 0.245 | 0.037 | Diamine oxidase inhibitor | 0.037 0.027 CID_998 | CID_998 | |
| 0.05 | 0.289 | 0.538 | Aldehyde dehydrogenase inhibitor | 0.538 0.004 CID_998 | CID_998 | |
| 0.016 | 0.257 | 0.064 | Adenylate cyclase 1 inhibitor | 0.064 0.015 CID_998 | CID_998 | |
| 0.004 | 0.25 | 0.031 | Uridine phosphorylase inhibitor | 0.031 0.017 CID_998 | CID_998 | |
| 0.013 | 0.26 | 0.088 | Plasminogen activator inhibitor | 0.088 0.021 CID_998 | CID_998 | |
| 0.034 | 0.284 | 0.139 | HIV-1 integrase (Overall Integration) inhibitor | 0.139 0.029 CID_998 | CID_998 | |
| 0.024 | 0.275 | 0.088 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.088 0.024 CID_998 | CID_998 | |
| 0.007 | 0.261 | 0.046 | Guanylate cyclase inhibitor | 0.046 0.026 CID_998 | CID_998 | |
| 0.018 | 0.272 | 0.049 | Human rhinovirus A protease inhibitor | 0.049 0.044 CID_998 | CID_998 | |
| 0.022 | 0.276 | 0.105 | Elastase 1 inhibitor | 0.105 0.017 CID_998 | CID_998 | |
| 0.035 | 0.289 | 0.095 | Protein kinase C gamma inhibitor | 0.092 0.091 CID_998 0.095 0.087 CID_259381 | CID_259381 | |
| 0.018 | 0.272 | 0.053 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.053 0.012 CID_998 | CID_998 | |
| 0.05 | 0.308 | 0.254 | Phospholipase A2 inhibitor | 0.254 0.022 CID_998 | CID_998 | |
| 0.031 | 0.29 | 0.08 | Carbonic anhydrase VI inhibitor | 0.08 0.057 CID_998 | CID_998 | |
| 0.047 | 0.307 | 0.151 | Photosensitizer | 0.151 0.031 CID_998 | CID_998 | |
| 0.035 | 0.295 | 0.079 | Glutathione S-transferase inhibitor | 0.079 0.063 CID_998 | CID_998 | |
| 0.028 | 0.288 | 0.12 | Ornithine decarboxylase inhibitor | 0.12 0.025 CID_998 | CID_998 | |
| 0.004 | 0.266 | 0.017 | Alpha 2c adrenoreceptor agonist | 0.017 0.016 CID_998 | CID_998 | |
| 0.025 | 0.289 | 0.153 | Alcohol dehydrogenase inhibitor | 0.153 0.019 CID_998 | CID_998 | |
| 0.031 | 0.296 | 0.118 | Caspase 9 inhibitor | 0.118 0.01 CID_998 | CID_998 | |
| 0.071 | 0.337 | 0.161 | Interferon gamma antagonist | 0.161 0.065 CID_998 | CID_998 | |
| 0.021 | 0.288 | 0.131 | Carbonic anhydrase XIII inhibitor | 0.131 0.026 CID_998 | CID_998 | |
| 0.008 | 0.276 | 0.049 | Alpha 1d adrenoreceptor agonist | 0.049 0.017 CID_998 | CID_998 | |
| 0.012 | 0.28 | 0.06 | NMDA receptor glycine site agonist | 0.06 0.046 CID_998 | CID_998 | |
| 0.02 | 0.289 | 0.059 | Heparanase inhibitor | 0.059 0.025 CID_998 | CID_998 | |
| 0.021 | 0.291 | 0.056 | NMDA receptor agonist | 0.056 0.053 CID_998 | CID_998 | |
| 0.114 | 0.387 | 0.285 | Caspase 3 stimulant | 0.285 0.087 CID_998 | CID_998 | |
| 0.042 | 0.316 | 0.14 | ABCA1 expression enhancer | 0.14 0.02 CID_998 | CID_998 | |
| 0.048 | 0.322 | 0.109 | Protein kinase stimulant | 0.109 0.106 CID_998 | CID_998 | |
| 0.035 | 0.319 | 0.087 | Bile acid receptor antagonist | 0.087 0.081 CID_998 | CID_998 | |
| 0.011 | 0.296 | 0.028 | Complement factor 1s inhibitor | 0.028 0.011 CID_998 | CID_998 | |
| 0.017 | 0.303 | 0.109 | Lipase inhibitor | 0.109 0.023 CID_998 | CID_998 | |
| 0.067 | 0.356 | 0.165 | CF transmembrane conductance regulator agonist | 0.165 0.053 CID_998 | CID_998 | |
| 0.026 | 0.317 | 0.094 | Urease inhibitor | 0.094 0.073 CID_998 | CID_998 | |
| 0.017 | 0.311 | 0.044 | Purinergic P2X4 antagonist | 0.044 0.036 CID_998 | CID_998 | |
| 0.016 | 0.315 | 0.063 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.063 0.027 CID_998 | CID_998 | |
| 0.014 | 0.315 | 0.103 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 CID_998 | CID_998 | |
| 0.038 | 0.342 | 0.139 | Microtubule formation inhibitor | 0.139 0.044 CID_998 | CID_998 | |
| 0.036 | 0.341 | 0.132 | Electrolyte absorption antagonist | 0.132 0.028 CID_998 | CID_998 | |
| 0.105 | 0.411 | 0.247 | Nitric-oxide synthase stimulant | 0.247 0.035 CID_998 | CID_998 | |
| 0.042 | 0.358 | 0.088 | D-Ala-D-Ala ligase inhibitor | 0.088 0.048 CID_998 | CID_998 | |
| 0.026 | 0.346 | 0.178 | Cystathionine beta-synthase inhibitor | 0.178 0.03 CID_998 | CID_998 | |
| 0.014 | 0.334 | 0.067 | Myc inhibitor | 0.067 0.021 CID_259381 | CID_259381 | |
| 0.013 | 0.335 | 0.132 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.132 0.01 CID_998 | CID_998 | |
| 0.072 | 0.397 | 0.284 | DNA synthesis inhibitor | 0.284 0.05 CID_998 0.186 0.145 CID_259381 | CID_998 | |
| 0.034 | 0.365 | 0.101 | Carbonic anhydrase III inhibitor | 0.101 0.061 CID_998 | CID_998 | |
| 0.056 | 0.387 | 0.206 | Non-steroidal antiinflammatory agent | 0.206 0.066 CID_998 | CID_998 | |
| 0.007 | 0.342 | 0.045 | Thymidylate synthase inhibitor | 0.045 0.035 CID_998 | CID_998 | |
| 0.027 | 0.364 | 0.08 | Keratolytic | 0.08 0.048 CID_998 | CID_998 | |
| 0.044 | 0.386 | 0.289 | 3C-Like protease (SARS coronavirus) inhibitor | 0.289 0.003 CID_998 | CID_998 | |
| 0.032 | 0.376 | 0.102 | Falcipain inhibitor | 0.102 0.053 CID_998 | CID_998 | |
| 0.095 | 0.444 | 0.297 | Apoptosis antagonist | 0.297 0.087 CID_998 | CID_998 | |
| 0.012 | 0.363 | 0.332 | Protein 50S ribosomal subunit inhibitor | 0.332 0.003 CID_998 | CID_998 | |
| 0.057 | 0.408 | 0.158 | Tumour necrosis factor antagonist | 0.158 0.09 CID_998 | CID_998 | |
| 0.044 | 0.403 | 0.121 | Aurora-C kinase inhibitor | 0.121 0.104 CID_259381 | CID_259381 | |
| 0.008 | 0.368 | 0.028 | Caspase 6 inhibitor | 0.028 0.027 CID_998 | CID_998 | |
| 0.009 | 0.373 | 0.106 | TRPA1 antagonist | 0.106 0.016 CID_998 | CID_998 | |
| 0.038 | 0.403 | 0.173 | Insulin sensitizer | 0.173 0.104 CID_998 | CID_998 | |
| 0.011 | 0.377 | 0.092 | Monophenol monooxygenase inhibitor | 0.092 0.082 CID_998 | CID_998 | |
| 0.029 | 0.406 | 0.17 | Pyruvate kinase inhibitor | 0.17 0.1 CID_998 | CID_998 | |
| 0.019 | 0.397 | 0.106 | Alkylator | 0.106 0.081 CID_998 | CID_998 | |
| 0.005 | 0.388 | 0.075 | Aromatase inhibitor | 0.075 0.03 CID_998 | CID_998 | |
| 0.041 | 0.428 | 0.252 | Interleukin 4 antagonist | 0.252 0.013 CID_998 | CID_998 | |
| 0.014 | 0.402 | 0.135 | CYP2A6 inhibitor | 0.135 0.021 CID_998 | CID_998 | |
| 0.035 | 0.426 | 0.158 | NADPH oxidase inhibitor | 0.158 0.05 CID_998 | CID_998 | |
| 0.029 | 0.435 | 0.259 | Amylase inhibitor | 0.259 0.026 CID_998 | CID_998 | |
| 0.056 | 0.477 | 0.201 | Transcription factor STAT inhibitor | 0.201 0.137 CID_998 | CID_998 | |
| 0.031 | 0.465 | 0.186 | Interleukin 5 antagonist | 0.186 0.006 CID_998 | CID_998 | |
| 0.01 | 0.457 | 0.077 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.077 0.054 CID_998 | CID_998 | |
| 0.05 | 0.51 | 0.21 | Hypoxia-inducible factor 1 alpha inhibitor | 0.21 0.14 CID_998 | CID_998 | |
| 0.02 | 0.484 | 0.108 | Factor XII inhibitor | 0.108 0.031 CID_998 | CID_998 | |
| 0.043 | 0.53 | 0.298 | Transcription factor NF kappa B inhibitor | 0.298 0.095 CID_998 | CID_998 | |
| 0.023 | 0.512 | 0.244 | Mannose-6-phosphate isomerase inhibitor | 0.244 0.013 CID_998 | CID_998 | |
| 0.038 | 0.538 | 0.217 | Transcription factor STAT3 inhibitor | 0.217 0.114 CID_998 | CID_998 | |
| 0.031 | 0.55 | 0.134 | Nitric oxide antagonist | 0.134 0.113 CID_998 | CID_998 | |
| 0.004 | 0.551 | 0.055 | 5 Hydroxytryptamine 2C agonist | 0.055 0.024 CID_259381 | CID_259381 | |
| 0.039 | 0.606 | 0.332 | Antibacterial | 0.332 0.113 CID_998 | CID_998 | |
| 0.02 | 0.594 | 0.092 | Thioredoxin reductase inhibitor | 0.092 0.038 CID_998 | CID_998 | |
| 0.014 | 0.607 | 0.101 | Beta glucuronidase inhibitor | 0.101 0.067 CID_998 | CID_998 | |
| 0.011 | 0.635 | 0.133 | DNA intercalator | 0.133 0.05 CID_998 | CID_998 | |
| 0.004 | 0.631 | 0.049 | Xanthine dehydrogenase inhibitor | 0.049 0.047 CID_998 | CID_998 | |
| 0.006 | 0.657 | 0.077 | CDC25B inhibitor | 0.077 0.03 CID_998 | CID_998 | |
| 0.036 | 0.74 | 0.666 | Antiinflammatory | 0.666 0.037 CID_998 | CID_998 | |
| 0.019 | 0.765 | 0.13 | Interleukin 2 antagonist | 0.13 0.033 CID_998 | CID_998 | |
| 0.012 | 0.78 | 0.204 | Interleukin 6 antagonist | 0.204 0.039 CID_998 | CID_998 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |